Maturation-dependent susceptibility to monocyte-mediated cytotoxicity in acute myeloid leukemia

Leukemia

Volumn 8, Issue 8, 1994, Pages 1392-1400

  Van De Loosdrecht, A A ^a   Ossenkoppele, G J ^a   Beelen, R H J ^b   Broekhoven, M G ^a   Van Hooff, M H A ^a   Drager A M ^a   Huijgens, P C ^a   Langenhuijsen, M M A C ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CD34 ANTIGEN; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HLA DR ANTIGEN; INTERLEUKIN 3; MICROSOMAL AMINOPEPTIDASE; TUMOR NECROSIS FACTOR ALPHA;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CELL MATURATION; CELL MEDIATED CYTOTOXICITY; COLORIMETRY; CONTROLLED STUDY; HUMAN; HUMAN CELL; MONOCYTE; PRIORITY JOURNAL;

EID: 0028015974     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Fidler IJ. Macrophages and metastasis - a biological approach to cancer therapy: presidential address. Cancer Res 1985;45: 4714-4726.
2. Andreesen R, Hennemann B. Adoptive immunotherapy with autologous macrophages: current status and future perspectives. Pathobiol 1991;59:259-263.
3. Andreesen R, Scheibenbogen C, Brugger W, Krause S, Meerpohl HG, Leser HC, Engler H, Löhr CW. Adoptive transfer of tumor cytotoxic macrophages generated in vitro from circulating blood monocytes: a new approach to cancer immunotherapy. Cancer Res 1990;50:7450-7456.
4. Faradji A, Bohbot A, Schmitt-Goguel M, Roeslin N, Dumont S, Wiesel ML, Lallot C, Eber M, Bartholeyns J, Poindron P, Morand G, Witz JP, Oberling F. Phase I trial of intravenous infusion of exvivo-activated autologous blood-derived macrophages in patients with non-small-cell lung cancer: toxicity and immunomodulatory effects. Cancer Immunol Immunother 1991;33:319-326.
5. Faradji A, Bohbot A, Frost H, Schmitt-Goguel M, Siffert JC, Dufour P, Eber M, Lallot C, Wiesel ML, Bergerat JP, Oberling F. Phase I study of liposomal MTP-PE-activated autologous monocytes administered intraperitoneally to patients with peritoneal carcinomatosis. J Clin Oncol 1991;9:1251-1269.
6. Grabstein KH, Urdal DL, Tushinski RJ, Mochizuki DY, Price VL, Cantrell MA, Gillis S, Conlon PJ. Induction of macrophage tumoricidal activity by granulocyte-macrophage colony-stimulating factor. Science 1986;232:506-508.
7. Cannistra SA, Vellenga E, Groshek P, Rambaldi A, Griffin JD. Human granulocyte-monocyte colony-stimulating factor and interleukin-3 stimulate monocyte cytotoxicity through a tumor necrosis factor-dependent mechanism. Blood 1988;71:672-676.
8. Hamilton JA. Colony stimulating factors, cytokines and monocyte-macrophages - some controversies. Immunol Today 1993; 14:18-24.
9. Schultz RM. The role of cytokines in macrophage activation. Prog Drug Res 1990;35:109-138.
10. Van de Loosdrecht AA, Beelen RHJ, Ossenkoppele GJ, Broekhoven MG, Langenhuijsen MMAC. Cellular and cytokine dependent monocyte-mediated leukemic cell death: modulation by interferon-γ and tumor necrosis factor-α. Exp Hematol 1993; 21:461-468.
11. Van de Loosdrecht AA, Ossenkoppele GJ, Beelen RHJ, Broekhoven MG, Langenhuijsen MMAC. Role of interferon-γ and tumour necrosis factor-α in monocyte-mediated cytostasis and cytotoxicity against a human histiocytic lymphoma cell line. Cancer Immunol Immunother 1992;34:393-398.
12. Horn D, Van der Bosch J, Rüller S, Schlaak M. Suppression of tumor cell susceptibility to monocyte-induced cell death by growth-inhibitory signals generated during monocyte/tumor cell interaction. J Cell Biochem 1991;45:213-223.
13. 2-integrins. Cancer Res 1993;53:4399-4407.
14. Lotzová E, Savary CA, Herberman RB. Induction of NK cell activity against fresh human leukemia in culture with interleukin 2. J Immunol 1987;138:2718-2727.
15. Tratkiewicz JA, Szer J, Boyd RL. Lymphokine-activated killer cytotoxicity against leukaemic blast cells. Clin Exp Immunol 1990;80:94-99.
16. Dawson MM, Johston D, Taylor GM, Moore M. Lymphokine activated killing of fresh human leukaemias. Leuk Res 1986;10: 683-688.
17. Van de Loosdrecht AA, Ossenkoppele GJ, Beelen RJH, Broekhoven MG, Schweitzer CM, Langenhuijsen MMAC. In vitro purging of clonogenic leukemic cells from human bone marrow by IFNγ-activated monocytes. Cancer Immunol Immunother 1994;38:346-352.
18. Bennet JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative group. Ann Intern Med 1985;103:626-629.
19. Bennet JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C. Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML-M0). Br J Haematol 1991;78:325-329.
20. Sündstrom C, Nilsson K. Establishment and characterization of a human histiocytic lymphoma cell line (U937). Int J Cancer 1976;17:565-577.
21. Tsuchiya S, Yamabe M, Yamaguchi Y, Kobayashi Y, Konno T, Tada K. Establishment and characterization of a human monocytic leukemia cell line (THP-1). Int J Cancer 1980;26:171-176.
22. Gallagher R, Collins S, Trujillo J, McCredie K, Ahearn M, Tsai S, Metzgar R, Aulakh G, Ting R, Rucetti F, Gallo R. Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia. Blood 1979; 54:713-733.
23. Lozzio CB, Lozzio BB. Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. Blood 1975; 45:321-334.
24. Koeffler CB, Golde DW. Acute myelogenous leukemia: a human cell line responsive to colony-stimulating activity. Science 1978; 200:1153-1158.
25. Rebel VI, Ossenkoppele GJ, Van de Loosdrecht AA, Wijermans PW, Beelen RJH, Langenhuijsen MMAC. Monocytic differentiation induction by MC903, a novel vitamin D analogue. Leuk Res 1992;16:443-451.
26. Van de Loosdrecht AA, Nennie E, Ossenkoppele GJ, Beelen RHJ, Langenhuijsen MMAC. Cell mediated cytotoxlcity against U937 cells by human monocytes and macrophages in a modified colorimetric MTT assay. J Immunol Methods 1991;141:15-22.
27. Terstappen LWMM, Safford M, Könneman S, Loken MR, Zurlutter K, Büchner T, Hiddeman W, Wörmann B. Flow cytometric characterization of acute myeloid leukemia. Part II. Phenotypic heterogeneity at diagnosis. Leukemia 1991;5:757-767.
28. Löwenberg B, Touw IP. Hematopoietic growth factors and their receptors in acute leukemia. Blood 1993;81:281-292.
29. Elbaz O, Budel LM, Hoogerbrugge H, Touw IP, Delwel R, Mahmoud LA, Löwenberg B. Tumor necrosis factor regulates the expression of granulocyte-macrophage colony-stimulating factor and interleukin-3 receptors on human acute myeloid leukemia cells. Blood 1991;77:989-995.
30. Elbaz O, Mahmoud L, Touw IP, Löwenberg B. Analysis of TNF receptors on human leukaemia cells by affinity cross-linking. Br J Haematol 1992;81:530-532.
31. Delwel R, Van Buitenen C, Löwenberg B, Touw IP. Involvement of tumor necrosis factor (TNF) receptors p55 and p75 in TNF responses of acute myeloid leukemia blasts in vitro. Blood 1992; 80:1798-1803.
32. Brach MA, Gruss HJ, Asano Y, De Vos S, Ludwig WD, Mertelsman R, Hermann F. Synergy of interleukin 3 and tumor necrosis factor-α in stimulating clonal growth of acute myelogenous leukemia blasts is the result of induction of secondary hematopoietic cytokines by tumor necrosis factor-α. Cancer Res 1992; 52:2197-2201.
33. Watson RB, Galvani DW, Nash JR, Cawley JC. γIFN receptor expression in haemic malignancies. Leuk Res 1990;14:657-660.
34. Murohashi I, Hoang T. Interferon-gamma enhances growth factor-dependent proliferation of clonogenic cells in acute myeloblastic leukemia. Blood 1991;78:1085-1089.
35. DeMarco R, Ensor JE, Hasday JD. Tumor-stimulated release of tumor necrosis factor-α by human monocyte-derived macrophages. Cell Immunol 1992;140:304-318.
36. Nathan CF. Secretory products of macrophages. J Clin Invest 1987;79:319-326.
37. Van de Loosdrecht AA, Ossenkoppele GJ, Beelen RHJ, Broekhoven MG, Dräger AM, Langenhuijsen MMAC. Apoptosis in TNF-α dependent monocyte mediated leukemic cell death. A functional, morphological and flow-cytometrical analysis. Exp Hematol 1993;21:1628-1639.
38. Delia D, Aiello A, Solingo D, Fontanella E, Pezzella F, Piertti MA, Pota GD. Bcl-2 proto-oncogene expression in normal and neoplastic human myeloid cells. Blood 1992;79:1291-1298.
39. Mariano MT, Moretti L, Donelli A, Grantini M, Montagnani G, Dipriso AU, Torelli G, Torelli U, Narni F. Bcl-2 gene expression in hematopoietic cell differentiation. Blood 1992;80:768-775.